71 related articles for article (PubMed ID: 21456504)
1. Immunohistochemical evaluation of Pi class glutathione S-transferase expression in invasive breast carcinoma.
Vecanova J; Hodorova I; Mihalik J; Benicky M; Kluchova D; Rybarova S
Bratisl Lek Listy; 2011; 112(2):67-70. PubMed ID: 21456504
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferase Pi expression in invasive breast cancer and its relation with the clinical outcome.
Franco RL; Schenka NG; Schenka AA; Rezende LF; Gurgel MS
J BUON; 2012; 17(2):259-64. PubMed ID: 22740203
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
Huang J; Tan PH; Thiyagarajan J; Bay BH
Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
[TBL] [Abstract][Full Text] [Related]
4. MRP1 and GSTp1 expression in non-small cell lung cancer does not correlate with clinicopathological parameters: A Slovakian population study.
Rybárová S; Hodorová I; Mihalik J; Mirossay L
Acta Histochem; 2014 Oct; 116(8):1390-8. PubMed ID: 25258012
[TBL] [Abstract][Full Text] [Related]
5. Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.
Yang SJ; Wang DD; Li J; Xu HZ; Shen HY; Chen X; Zhou SY; Zhong SL; Zhao JH; Tang JH
Gene; 2017 Aug; 623():5-14. PubMed ID: 28438694
[TBL] [Abstract][Full Text] [Related]
6. Studies on p53 immunolocalisation in breast cancer and its prognostic significance.
Meenakshi A; Manoharan V
Hum Antibodies; 1999; 9(3):171-6. PubMed ID: 10690631
[TBL] [Abstract][Full Text] [Related]
7. Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancers.
Arai T; Miyoshi Y; Kim SJ; Akazawa K; Maruyama N; Taguchi T; Tamaki Y; Noguchi S
Eur J Surg Oncol; 2008 Jul; 34(7):734-8. PubMed ID: 17764884
[TBL] [Abstract][Full Text] [Related]
8. Chromatin texture, DNA index, and S-phase fraction in primary breast carcinoma cells analysed by laserscanning cytometry.
Kuliffay P; Sanislo L; Galbavy S
Bratisl Lek Listy; 2010; 111(1):4-8. PubMed ID: 20429304
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.
Esteller M; Corn PG; Urena JM; Gabrielson E; Baylin SB; Herman JG
Cancer Res; 1998 Oct; 58(20):4515-8. PubMed ID: 9788592
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin D in invasive ductal NOS, medullary, lobular and mucinous breast carcinoma. An immunohistochemical study.
Bedner E; Harezga B; Osborn M; Domagała W
Pol J Pathol; 1995; 46(1):11-5. PubMed ID: 7780691
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of glutathione S-transferase pi correlates with poorly differentiated grade in patients with oral squamous cell carcinoma.
Ma HL; Yu C; Liu Y; Tan YR; Qiao JK; Yang X; Wang LZ; Li J; Chen Q; Chen FX; Zhang ZY; Zhong LP
J Oral Pathol Med; 2015 Mar; 44(3):193-200. PubMed ID: 25047743
[TBL] [Abstract][Full Text] [Related]
13. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.
Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C
Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
[TBL] [Abstract][Full Text] [Related]
15. Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy.
Wong H; Lau S; Cheung P; Wong TT; Parker A; Yau T; Epstein RJ
BMC Cancer; 2014 Nov; 14():826. PubMed ID: 25385074
[TBL] [Abstract][Full Text] [Related]
16. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining and Southern blot hybridization for glutathione S-transferase pi in mammary infiltrating ductal carcinoma.
Frierson HF; Gaffey MJ; Meredith SD; Boyd JC; Williams ME
Mod Pathol; 1995 Aug; 8(6):643-7. PubMed ID: 8532698
[TBL] [Abstract][Full Text] [Related]
18. Response of glutathione S-transferase Pi (GSTP1) to neoadjuvant therapy in rectal adenocarcinoma.
Bedford MR; Anathhanam S; Saleh D; Hickson A; McGregor AK; Boyle K; Burke D
Colorectal Dis; 2012 Dec; 14(12):1483-8. PubMed ID: 22390478
[TBL] [Abstract][Full Text] [Related]
19. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll R; Mitze M; Frixen UH; Birchmeier W
Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
[TBL] [Abstract][Full Text] [Related]
20. Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers.
Arai T; Miyoshi Y; Kim SJ; Taguchi T; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2006 Nov; 100(2):169-76. PubMed ID: 16791478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
